A naukri.com initiative
Bioengineer
1w
93
Image Credit: Bioengineer
TRxA Unveils 2025 Call for Proposals Aimed at Academic Researchers
- The Critical Path Institute (C-Path) has officially announced the launch of its 2025 global Request for Proposals (RFP) for its innovative Bridging Research and Innovation in Drug Development Grants under the umbrella of the Translational Therapeutics Accelerator (TRxA).
- The BRIDGe initiative seeks to empower academic researchers around the world who are pioneering advancements in drug development and therapeutics.
- As part of the announcement, Dr. Maaike Everts, the Executive Director of TRxA, shared her enthusiasm regarding the new cycle of funding opportunities.
- The BRIDGe grants will provide a comprehensive suite of resources critical to advancing drug development initiatives.
- Eligible platforms for this cycle of funding encompass a variety of therapeutic modalities, including small molecules, protein-based therapeutics, and in vivo gene-based therapies.
- C-Path is particularly interested in projects focused on a few key therapeutic areas, which include brain health, pediatrics, and rare and orphan diseases.
- To facilitate the application process for these grants, C-Path will host a free webinar designed to provide potential applicants with vital information.
- For those looking for further information, C-Path offers a dedicated webpage featuring detailed guidance on the RFP and application process.
- The BRIDGe initiative represents an important evolution in how academic researchers can secure the support necessary for their important work.
- Initiatives like BRIDGe are crucial for paving the way for future success.
Read Full Article
5 Likes
For uninterrupted reading, download the app